Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD)   MAY 2016 , Volume 10 , Number 3; Page(s) 51 To 55.
 
Paper: 

EFFICACY OF COMBINED PLASMAPHERESIS AND INTRAVENOUS IMMUNOGLOBULIN THERAPY IN KIDNEY TRANSPLANT PATIENTS WITH CHRONIC ANTIBODY-MEDIATED REJECTION

 
 
Author(s):  OGUZ EBRU GOK*, OKYAY GULAY ULUSAL, AKOGLU HADIM, MERHAMETSIZ OZGUR, YILDIRIM TOLGA, CANBAKAN BASOL, AYLI MEHMET DENIZ
 
* DEPARTMENT OF NEPHROLOGY, ANKARA DISKAPI YILDIRIM BEYAZIT EDUCATION AND RESEARCH HOSPITAL, ANKARA, TURKEY
 
Abstract: 

Introduction: Antibody-mediated rejections (AMRs) are critical clinical issues encountered in short- and long-term follow-up of kidney transplant patients. Whereas plasmapheresis is a mainstay treatment option in acute AMR cases, there is a paucity of data regarding its efficacy in management of chronic AMR. This report describes our experience addressing this issue.
Materials And Methods: We retrospectively investigated the data of 7 kidney transplant patients diagnosed with chronic AMR who were on 5 sessions of plasmapheresis (1 to 2 volume exchanges with fresh frozen plasma) on alternate days and 200 mg/kg of intravenous immunoglobulin after each session of plasmapheresis.
Results: At 6 months after the initiation of treatment, 6 patients experienced partially improved kidney function. One patient had no response and her kidney function progressively deteriorated.
Conclusions: Our preliminary results are encouraging for the combination of plasmapheresis and intravenous immunoglobulin as an adjunctive therapy for kidney transplant patients suffering from chronic AMR.

 
Keyword(s): CHRONIC ANTIBODY-MEDIATED REJECTION, IMMUNOGLOBULIN, KIDNEY TRANSPLANTATION, PLASMAPHERESIS
 
 
References: 
  • Not Registered.
  •  
  •  
 
Citations: 
  • Not Registered.
 
+ Click to Cite.
APA: Copy

OGUZ, E., & OKYAY, G., & AKOGLU, H., & MERHAMETSIZ, O., & YILDIRIM, T., & CANBAKAN, B., & AYLI, M. (2016). EFFICACY OF COMBINED PLASMAPHERESIS AND INTRAVENOUS IMMUNOGLOBULIN THERAPY IN KIDNEY TRANSPLANT PATIENTS WITH CHRONIC ANTIBODY-MEDIATED REJECTION. IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD), 10(3), 51-55. https://www.sid.ir/en/journal/ViewPaper.aspx?id=510617



Vancouver: Copy

OGUZ EBRU GOK, OKYAY GULAY ULUSAL, AKOGLU HADIM, MERHAMETSIZ OZGUR, YILDIRIM TOLGA, CANBAKAN BASOL, AYLI MEHMET DENIZ. EFFICACY OF COMBINED PLASMAPHERESIS AND INTRAVENOUS IMMUNOGLOBULIN THERAPY IN KIDNEY TRANSPLANT PATIENTS WITH CHRONIC ANTIBODY-MEDIATED REJECTION. IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD). 2016 [cited 2021September20];10(3):51-55. Available from: https://www.sid.ir/en/journal/ViewPaper.aspx?id=510617



IEEE: Copy

OGUZ, E., OKYAY, G., AKOGLU, H., MERHAMETSIZ, O., YILDIRIM, T., CANBAKAN, B., AYLI, M., 2016. EFFICACY OF COMBINED PLASMAPHERESIS AND INTRAVENOUS IMMUNOGLOBULIN THERAPY IN KIDNEY TRANSPLANT PATIENTS WITH CHRONIC ANTIBODY-MEDIATED REJECTION. IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD), [online] 10(3), pp.51-55. Available: https://www.sid.ir/en/journal/ViewPaper.aspx?id=510617.



 
  pdf-File
Yearly Visit 56
 
 
Latest on Blog
Enter SID Blog